Salesforce

Valuation Analysis

About the Company

Salesforce en bref

Salesforce (CRM) is currently trading at 159,55 € with a market capitalization of 130,7 Md €. The trailing P/E ratio stands at 21.32x, with a forward P/E of 11.86x. The 52-week range spans from 126,86 € to 233,32 €; the current price is 31.6% below the yearly high. Year-over-year revenue growth stands at +13.3%. The net profit margin stands at 18.73%.

💰 Dividende

Salesforce pays an annual dividend of 1,53 € per share, representing a yield of 0.96%. The payout ratio stands at 19.56%.

📊 Avis des analystes

53 analystes évaluent Salesforce (CRM) au consensus : Acheter. L'objectif de cours moyen est de 209,57 €, soit un potentiel de +31.36% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 138,72 € à 411,83 €.

Salesforce : la thèse d'investissement en détail

Salesforce (CRM) operates in the Technology — specifically Software - Application — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 13.3% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 52.2% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. With a gross margin near 77.64%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

Valorisation en contexte

With a PEG ratio of 0.76, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

À surveiller

• The forward P/E of 11.86x is meaningfully below the trailing 21.32x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 31.36% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to market-like volatility, elevated short interest (6.56%), higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Salesforce?

Compare top-rated brokers — low fees, trusted providers, fully regulated.